DBV Technologies S.A. reported $5.0M of revenue over the trailing twelve months, +29% on the year before. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.0M (to Q2 2026). Net income: −$176M, trailing twelve months to Q2 2026. Free cash flow: −$171M, trailing twelve months to Q2 2026. Operating margin: −5193%, trailing twelve months to Q2 2026.

DBVTDBV Technologies S.A.

Healthcare

$9.80-38% 1Y

$9.80

$9.5152 weeks$24.54

DBVT as reported

DBV Technologies S.A. reported $5.0M of revenue over the trailing twelve months, +29% on the year before. 8 reported series are charted on this page, each one as filed.

$5.0M

Revenue, trailing twelve months · to Q2 2026 · +29% against the twelve months before

Net income: −$176M
Net income · +44% year on year · trailing twelve months to Q2 2026
Free cash flow: −$171M
Free cash flow · +92% year on year · trailing twelve months to Q2 2026
Operating margin: −5193%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for DBVT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.0M	+29%	Q2 2026
Net income	−$176M	+44%	Q2 2026
EPS	−$0.70	−37%	Q2 2026
Operating margin	−5193%	n/a	Q2 2026
Net margin	−5159%	n/a	Q2 2026
ROE	−129%	n/a	Q2 2026
ROA	−79%	n/a	Q2 2026
Free cash flow	−$171M	+92%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.